Nicholas R Latimer (N R Latimer, Nick Latimer, Nicholas Latimer)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Venues

PharmacoEconomics

Statistical methods in medical research

BMJ medicine

Health technology assessment (Winchester, England)

University of Sheffield

University of Sheffield (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Sheffield Jan 01 2014

United Kingdom

Senior Research Fellow :: ScHARR

University of Sheffield Jun 01 2008 - Jan 01 2014

United Kingdom

Research Fellow :: ScHARR

Roche Products Ltd Jul 01 2007 - Jun 01 2008

United Kingdom

Health Economist

Queen Mary University of London Mar 01 2006 - Jul 01 2007

United Kingdom

Health Economics Fellow :: Centre for Health Sciences

Education History

University of Sheffield Oct 01 2009 - Oct 01 2012

United Kingdom

PHD :: School of Health and Related Research

University of York Oct 01 2003 - Oct 01 2004

United Kingdom

MSC

University of Nottingham Oct 01 2000 - Oct 01 2003

United Kingdom

BSC

Publications

Jen-Yu Amy Chang, James B Chilcott, Nicholas R Latimer
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments. PharmacoEconomics 42 (5) (2024)
Nicholas R Latimer, Mark J Rutherford
Mixture and Non-mixture Cure Models for Health Technology Assessment: What You Need to Know. PharmacoEconomics (2024)
Nicholas R Latimer, Kurt Taylor, Anthony J Hatswell, Sophia Ho, Gabriel Okorogheye, Clara Chen, Inkyu Kim, John Borrill, David Bertwistle
An Evaluation of an Algorithm for the Selection of Flexible Survival Models for Cancer Immunotherapies: Pass or Fail? PharmacoEconomics (2024)
Jen-Yu Amy Chang, James B Chilcott, Nicholas R Latimer
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments. PharmacoEconomics 42 (5) (2024)
Jen-Yu Amy Chang, James B Chilcott, Nicholas R Latimer
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments. PharmacoEconomics 42 (5) (2024)
Jen-Yu Amy Chang, James B Chilcott, Nicholas R Latimer
Challenges and Opportunities in Interdisciplinary Research and Real-World Data for Treatment Sequences in Health Technology Assessments. PharmacoEconomics (2024)
Lizzie Swaby, Daniel C Perry, Kerry Walker, Prof Daniel Hind, Andrew Mills, Raveen Jayasuriya, Nikki Totton, Lauren Desoysa, Robin Chatters, Bridget Young, Frances C Sherratt, Nicholas R Latimer, Anju Devianee Keetharuth, Laura Kenison, Stephen J Walters, Adrian C Gardner, Sashin Ahuja, Laura Campbell, Sarah Greenwood, Ashley Cole, null null, null null, Chris Turtle, Simon Waterhouse, Neil Davidson, Masood Shafafy, Tom Marjoram, Neil Oxborrow, Fady Sedra, Mark Harris, Julian Leong, Jonathan Lucas, Darren Lui, Antonia Isaacson, Andy Bowey, Ian Harding, Evan Davies, Vinay Jasani, Almas Khan, Paul Thorpe, Thanos Tsirikos, Sam Sloan
Bracing Adolescent Idiopathic Scoliosis (BASIS) study - night-time versus full-time bracing in adolescent idiopathic scoliosis: study protocol for a multicentre, randomized controlled trial. Bone & joint open 4 (11) (2023)
Nicholas R Latimer, Amanda I Adler
Extrapolation beyond the end of trials to estimate long term survival and cost effectiveness. BMJ medicine 1 (1) (2022)
Nicholas R Latimer, Amanda I Adler
Extrapolation beyond the end of trials to estimate long term survival and cost effectiveness. BMJ medicine 1 (1) (2022)
Rebecca L Palmer, Munyaradzi Dimairo, Nicholas R Latimer, Elizabeth Cross, Marian C Brady, Pamela M Enderby, Audrey Bowen, Steven A Julious, Madeleine Harrison, Abualbishr Alshreef, Ellen Bradley, Arjun Bhadhuri, Timothy F Chater, Helen Hughes, Helen Witts, Esther Herbert, Cindy L Cooper
Computerised speech and language therapy or attention control added to usual care for people with long-term post-stroke aphasia: the Big CACTUS three-arm RCT. Health technology assessment (Winchester, England) 24 (19) (2021)
Nicholas R Latimer, Adrian Towse, Chris Henshall
Not cost-effective at zero price: valuing and paying for combination therapies in cancer. Expert review of pharmacoeconomics & outcomes research 21 (3) (2021)
Tushar Srivastava, Nicholas R Latimer, Paul Tappenden
Estimation of Transition Probabilities for State-Transition Models: A Review of NICE Appraisals. PharmacoEconomics 39 (8) (2021)
Nicholas R Latimer, Daniel Pollard, Adrian Towse, Chris Henshall, Lloyd Sansom, Robyn L Ward, Andrew Bruce, Carla Deakin
Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop. BMC health services research 21 (1) (2021)
Shirley A Thomas, Avril E R Drummond, Nadina B Lincoln, Rebecca L Palmer, Roshan das Nair, Nicholas R Latimer, Gemma L Hackney, Laura Mandefield, Stephen J Walters, Rachael D Hatton, Cindy L Cooper, Timothy F Chater, Timothy J England, Patrick Callaghan, Elizabeth Coates, Katie E Sutherland, Sarah Jacob Eshtan, Gogem Topcu
Behavioural activation therapy for post-stroke depression: the BEADS feasibility RCT. Health technology assessment (Winchester, England) 23 (47) (2020)
Nicholas R Latimer, Arjun Bhadhuri, Abualbishr Alshreef, Rebecca Palmer, Elizabeth Cross, Munyaradzi Dimairo, Steven Julious, Cindy Cooper, Pam Enderby, Marian C Brady, Audrey Bowen, Ellen Bradley, Madeleine Harrison
Self-managed, computerised word finding therapy as an add-on to usual care for chronic aphasia post-stroke: An economic evaluation. Clinical rehabilitation 35 (5) (2020)
Nicholas R Latimer, I R White, K Tilling, U Siebert
Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding. Statistical methods in medical research 29 (10) (2020)
Nicholas R Latimer, I R White, K R Abrams, U Siebert
Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Statistical methods in medical research 28 (8) (2018)

Nicholas R Latimer.css-eqlu8i{font-size:small;padding-left:4px;} (N R Latimer, Nick Latimer, Nicholas Latimer)

Publication Activity (10 Years)

Top Topics

Top Venues

Nicholas R Latimer (N R Latimer, Nick Latimer, Nicholas Latimer)